We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Proposes New Trial Cohort Criteria for HIV Drug Development
EMA Proposes New Trial Cohort Criteria for HIV Drug Development
October 10, 2013
The European Medicines Agency says HIV-infected patients recruited for clinical trials should be assessed based on their documented viral resistance, rather than treatment history, as viral resistance has become rarer with the introduction of newer and better drugs in the past few years.